Rathbones Group PLC Increases Position in Abbott Laboratories $ABT

robot
Abstract generation in progress

Rathbones Group PLC increased its stake in Abbott Laboratories (NYSE:ABT) by 3.6% in the fourth quarter, now owning 3,116,386 shares worth $390.45 million. Other hedge funds like Invesco Ltd., Alliancebernstein L.P., and Capital International Investors also significantly increased their holdings in ABT. The stock recently opened at $102.84, with a market capitalization of $179.11 billion, and analysts project 5.14 EPS for the current year.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin